This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sandhu, M. S. Articles by Wareham, N. J. Search for Related Content PubMed PubMed Citation Articles by Sandhu, M. S. Articles by Wareham, N. J.

Association between Insulin-Like Growth Factor-I

Insulin-Like Growth Factor-Binding Protein-1 Ratio and Metabolic and Anthropometric Factors in Men and Women

¹ Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge; ² Endocrine Sciences Research Group, Department of Medicine, University of Manchester, Manchester; and ³ Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Cambridge, United Kingdom

Several prospective observational studies have suggested that elevated circulating IGF-I levels are associated with an increased risk of cancer. These observations may provide a potential mechanism through which previously identified metabolic and anthropometric factors, such as obesity and elevated insulin and glucose levels, may operate. We therefore examined metabolic and anthropometric influences on circulating levels of insulin-like growth factor-I (IGF-I), insulin-like growth factor-binding protein-1 (IGFBP-1), and the IGF-I:IGFBP-1 ratio in a middle-aged population of 349 men and 492 women. IGF-I showed only modest inverse associations with indices of adiposity. However, we found that low IGFBP-I levels and an increased IGF-I:IGFBP-1 ratio were strongly associated with increased levels of insulin and glucose in men and women. Body mass index was also positively related to the IGF-I:IGFBP-1 ratio in men (P < 0.001) and women (P < 0.001), independent of metabolic correlates of IGFBP-1 and IGF-I. Similarly, waist:hip ratio and waist circumference were also associated with an increased IGF-I:IGFBP-1 ratio and low circulating IGFBP-1 levels. These findings suggest that individuals with greater fat mass and upper body obesity may have elevated levels of bioavailable or free IGF-I, which could, in part, mediate the reported associations among metabolic and anthropometric factors and cancer risk.

This article has been cited by other articles:

				E. Hypponen, B. J. Boucher, D. J. Berry, and C. Power 25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age: A Cross-Sectional Study in the 1958 British Birth Cohort Diabetes, February 1, 2008; 57(2): 298 - 305. [Abstract] [Full Text] [PDF]

				B. M. Birmann, E. Giovannucci, B. Rosner, K. C. Anderson, and G. A. Colditz Body Mass Index, Physical Activity, and Risk of Multiple Myeloma Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1474 - 1478. [Abstract] [Full Text] [PDF]

				R. M. Luque and R. D. Kineman Impact of Obesity on the Growth Hormone Axis: Evidence for a Direct Inhibitory Effect of Hyperinsulinemia on Pituitary Function Endocrinology, June 1, 2006; 147(6): 2754 - 2763. [Abstract] [Full Text] [PDF]

				I. Bray, D. Gunnell, J. M. P. Holly, N. Middleton, G. D. Smith, and R. M. Martin Associations of Childhood and Adulthood Height and the Components of Height with Insulin-Like Growth Factor Levels in Adulthood: A 65-Year Follow-Up of the Boyd Orr Cohort J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1382 - 1389. [Abstract] [Full Text] [PDF]

				D. R. Holsberger, G. M. Buchold, M. C. Leal, S. E. Kiesewetter, D. A. O'Brien, R. A. Hess, L. R. Franca, H. Kiyokawa, and P. S. Cooke Cell-Cycle Inhibitors p27Kip1 and p21Cip1 Regulate Murine Sertoli Cell Proliferation Biol Reprod, June 1, 2005; 72(6): 1429 - 1436. [Abstract] [Full Text] [PDF]

				W. H. Xu, C. E. Matthews, Y. B. Xiang, W. Zheng, Z. X. Ruan, J. R. Cheng, Y. T. Gao, and X. O. Shu Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women Am. J. Epidemiol., May 15, 2005; 161(10): 939 - 947. [Abstract] [Full Text] [PDF]

				A. McTiernan, B. Sorensen, Y. Yasui, S. S. Tworoger, C. M. Ulrich, M. L. Irwin, R. E. Rudolph, F. Z. Stanczyk, R. S. Schwartz, and J. D. Potter No Effect of Exercise on Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor Binding Protein 3 in Postmenopausal Women: a 12-Month Randomized Clinical Trial Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 1020 - 1021. [Full Text] [PDF]